News

Adrian Epstein, MD, PhD, a neonatology research fellow, and Sara Janos, MD, a pediatric radiology fellow, have co-authored a recent article that appears in Cell Stem Cell. 

Every spring the Duke University School of Medicine recognizes the achievements of a number of our colleagues with the presentation of School of Medicine faculty awards.

The survival rate of extremely preterm infants born from 2013 through 2018 in a large network of U.S. research centers improved to 78.3%, compared to 76% for infants born in the network from 2008 to 2012, according to researchers funded by the National Institutes of Health.

A. Eugene Washington, MD, Chancellor for Health Affairs, Duke University and President and CEO, Duke University Health System, recently announced the appointment of Jeffrey Ferranti, MD, MS, professor of pediatrics, family medicine and community health, and biostatistics and bioinformatics, as the Chief Digital Officer & Senior Vice President, Duke University Health System.

The Duke CTSI recently announced the publication of Oxysterols for Treatment of Perinatal Brain Injury, a case study documenting the translational journey of Duke researcher Eric Benner’s groundbreaking work to treat and reverse brain injuries in premature infants.

Adrian Epstein, MD, a second year fellow in the Division of Neonatology, was recently awarded the 2021 Marshall Klaus Neonatal-Perinatal Research Award for his project entitled, Disruption of oligodendrogenesis following sepsis-induced injury to the postnatal subventricular zone.

Tellus Therapeutics, Inc. announced a seed investment to develop the first treatment for newborns with white matter brain injury. Tellus is translating breakthrough science licensed from Duke University that originated in board-certified neonatologist Eric Benner’s research laboratory.

In this Alumni Spotlight interview, Lakshmi Katakam talks to us about her work treating patients in the largest NICU in the country at Texas Children’s Hospital, the lessons she learned as a fellow from her mentors and colleagues at Duke, and her love of nature, travel, and spending time with family.

A study funded by the National Institutes of Health suggests that keeping the hemoglobin level higher in the first weeks of life offers no advantage in survival or brain development for extremely low birth weight infants.

Duke’s Division of Neonatology and members of the Duke intensive care nursery (ICN) team continue to be at the forefront of quality improvement efforts that reduce sepsis, improve survival, and benefit the smallest, most vulnerable patients for the rest of their lives.